1. Čačev T, Jokić M, Lončar B, Križanac Š, Kapitanović S. Interleukin-6 -174 G/C polymorphism is not associated with IL-6 expression and susceptibility to sporadic colon cancer. DNA and Cell Biology 2010; 29(4): 177-182.
2. Kraljević Pavelić S, Sedić M, Hock K, Vučinić S, Jurišić D, Gehrig P, Scott M, Schlapbach R, Čačev T, Kapitanović S, Pavelić S. An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren’s disease. J Pathol 2009; 217: 524-533.
3. Čačev T, Radošević S, Križanac Š, Kapitanović S. Influence of interleukin-8 and interleulin-10 on sporadic colon cancer development and progression. Carcinogenesis 2008; 29(8):1572-1580.
4. Čačev T, Lončar B, Seiwerth S, Spaventi Š, Kapitanović S. Vascular endothelial growth factor polymorphisms -1154 G/A and -460 C/T are not associated with VEGF mRNA expression and susceptibility to sporadic colon cancer. DNA and Cell Biology 2008; 27(10):569-574.
5. Kraljević Pavelić S, Čačev T, Kralj M. A dual role of p21 (waf1/cip1) gene in apoptosis of HEp-2 treated with cisplatin or methotrexate. Cancer Gene Ther 2008; 15(9):576-590.
6. Sirotković-Skerlev M, Čačev T, Križanac S, Kulić A, Pavelić K, Kapitanović S. TNF alpha promoter polymorphisms analysis in benign and malignant breast lesions. Exp Mol Pathol 2007; 83:54-58.
7. Berković M, Čačev T, Zjačić-Rotkvić V, Kapitanović S. TNF-alpha Promoter Single Nucleotide Polymorphisms in Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology 2007; 84:346-352.
8. Pavelić K, Dedivitis RA, Kapitanović S, Čačev T, Guirado CR, Danić D, Radošević S, Brkić K, Pegan B, Križanac S, Kusić Z, Spaventi S, Bura M. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions. Mutat Res 2006; 599:45-57.
9. Čačev T, Jokić M, Spaventi R, Pavelić K, Kapitanović S. Loss of heterozygosity testing using real-time PCR analysis of single nucleotide polymorphisms. J Cancer Res Clin Oncol 2006; 132:200-204.
10. Kapitanović S, Čačev T, Antica M, Kralj M, Cavrić G, Pavelić K, Spaventi R. Effect of indomethacin on E-cadherin and beta-catenin expression in HT-29 colon cancer cells. Exp Mol Pathol 2006; 80:91-96.
11. Čačev T, Radošević S, Spaventi R, Pavelić K, Kapitanović S. NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. Gut 2005; 54(8):1129-1135.
12. Kapitanović S, Čačev T, Berković M, Popović Hadžija M, Radošević S, Seiwerth S, Spaventi Š, Pavelić K, Spaventi R. Nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma. J Clinical Pathology 2004; 57:1312-1318.
13. Kapitanović S, Čačev T, Radošević S, Spaventi Š, Spaventi R, Pavelić K. APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia. Exp Mol Pathol 2004; 77(3):193-200.
14. Pavelić K, Križanac Š, Čačev T, Popović-Hadžija M, Radošević S, Crnić I, Levanat S, Kapitanović S. Aberration of FHIT gene associated with increased tumor proliferation and decreased apoptosis – clinical evidence in lung and head and neck carcinomas. Mol Med 2001; 7:442-453.
15. Kapitanović S, Čačev T, Spaventi R, Pavelić K. Submerged gel electrophoresis on Spreadex gels – a new method for APC gene mutation detection. J Mol Med 2001; 79:333-337.
16. Popović Hadžija M, Kapitanović S, Radošević S, Čačev T, Mirt M, Kovačević D, Lukač J, Hadžija M, Spaventi R, Pavelić K. Loss of heterozygosity of DPC4 tumor suppressor gene in human sporadic colon cancer. J Mol Med 2001; 79:128-132.
